1 citations
,
July 2024 in “Skin Research and Technology” In this study, the researchers compared subcutaneous fat in the frontal and occipital scalp regions, which are affected and spared in androgenetic alopecia respectively, to better understand the role of subcutaneous fat in the condition's pathogenesis.
1 citations
,
August 2023 in “Irish Journal of Medical Science (1971 -)” In this study, approximately 24% of an Egyptian population reported hair loss following COVID-19 vaccination, confirmed through dermoscopy, although stress and infection were also possible contributing factors that need further investigation.
1 citations
,
January 2023 in “BMC Women's Health” This study reported a 3.86% prevalence of PCOS among tenth-grade schoolgirls in Guangzhou, with higher rates observed in obese girls compared to their lean counterparts.
1 citations
,
January 2023 in “Acta dermato-venereologica” This study found that individuals with alopecia areata in Germany, Austria, and Switzerland face significant out-of-pocket costs averaging 1,248€ annually, primarily for hair replacement products and cosmetics.
1 citations
,
October 2022 in “International Journal of Environmental Research and Public Health” This study found that Type 2 Diabetes was associated with a higher likelihood of Demodex folliculorum infestation in patients at a hospital in Peru.
1 citations
,
October 2022 in “Asian journal of medical sciences” This study found trichoscopy to be a highly sensitive, non-invasive method for diagnosing tinea capitis in children, which could be valuable in resource-limited settings lacking mycological culture facilities.
1 citations
,
January 2022 in “Transgender health” This study found that gender-affirming hormone therapy in transgender men increased acne and male pattern hair loss, while in transgender women, it led to melasma and female pattern hair loss.
1 citations
,
January 2022 in “Turkiye Klinikleri Journal of Dermatology” This study observed shifts in dermatological disease frequencies amid early COVID-19 pandemic lifestyle changes, noting significant increases in urticaria, drug eruptions, and alopecia areata, while bacterial and fungal infections decreased.
1 citations
,
April 2021 in “Nepal journal of dermatology, venereology & leprology” This study found that inadequate ferritin levels, rather than haemoglobin levels, indicated iron deficiency in women with telogen effluvium, alopecia areata, and female pattern hair loss.
1 citations
,
February 2021 in “Clinical, Cosmetic and Investigational Dermatology” This study found that lower serum ferritin levels were significantly associated with telogen effluvium compared to healthy subjects and may serve as a potential biomarker for its diagnosis.
1 citations
,
January 2019 in “International Journal of Advances in Medicine” This study found that infections were the most common skin issues in diabetics, especially among those with poorly controlled blood sugar.
1 citations
,
January 2018 in “International Journal of Research in Dermatology” In this study, the therapeutic response of topical minoxidil solution was not significantly enhanced by adding topical finasteride, questioning its additional value in treating male pattern androgenetic alopecia.
1 citations
,
April 2016 in “Journal of Investigative Dermatology” Patients with Focal Dermal Hypoplasia often experience skin, nail, hair, and bone issues, and may benefit from calcium and vitamin D supplements.
1 citations
,
May 2015 in “Journal of evolution of medical and dental sciences” In this study, a notable number of dermatology outpatients were found to have incidental scalp findings, indicating the importance of examining the scalp during clinical evaluations.
August 2026 in “Glosains Jurnal Sains Global Indonesia” In this cross-sectional study of Indonesian men, researchers observed a significant negative correlation between serum vitamin D levels and the severity of androgenetic alopecia, suggesting that lower vitamin D concentrations are associated with more severe hair loss, although causality was not established.
August 2026 in “Indian Journal of Palliative Care” This study found that adult cancer patients undergoing chemotherapy in India had high rates of malnutrition (57.1%), psychological distress (64.6%), and moderate-to-severe toxicities like alopecia (36.2%).
July 2026 in “The Professional Medical Journal” This study conducted in Peshawar, Pakistan, observed that individuals with Long COVID frequently reported systemic symptoms such as hair loss, headache, and fatigue, along with oral issues like loss of taste and dry mouth, highlighting the importance of incorporating oral symptom assessments in post-COVID care.
July 2026 in “Journal of the American Academy of Dermatology” Most young patients found oral minoxidil helpful for hair loss and were willing to continue using it.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that while 68% of adults were aware of minoxidil, only 42% had adequate knowledge of its proper use, with common side effects like scalp irritation and improper application frequently reported.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study observed that although 68% of the participants were aware of minoxidil, only 42% had proper knowledge of its correct use, with common misuse leading to scalp irritation and unwanted facial hair; highlighting the need for educational interventions for safer usage.
June 2026 in “European Medical Journal” This study found that among male and female patients at a dermatology clinic, higher severity of androgenetic alopecia was statistically associated with lower sexual function scores, although the findings should be interpreted cautiously due to sample size and methodological limitations.
May 2026 in “Pakistan Journal of Health Sciences” This study observed that among 84 patients with alopecia areata, the majority were aware of the condition before diagnosis and perceived it as hereditary or exacerbated by stress, highlighting the need for both medical and psychosocial support to enhance their quality of life.
May 2026 in “Australasian Journal of Dermatology” This study found that among Australians aged 15 and older, the lifetime prevalence of alopecia areata ranged from 1.2% to 2.3%, and the point prevalence ranged from 0.9% to 1.4%, emphasizing the need for better awareness and education about treatment options.
April 2026 in “Research Square” This study found that dental students' manual dexterity was weakly associated with their performance in skills-based assessments, while self-perceived skill levels showed no significant correlation with assessment outcomes, suggesting a potential benefit from focusing on dexterity enhancement in dental education.
April 2026 in “Clinical Dermatology Review” In this study, patients with keratosis pilaris exhibited significant quality of life impairment, with histopathology and dermoscopy revealing consistent skin and hair changes.
March 2026 in “Journal of Health Wellness and Community Research” In this study of young adults in Lahore, Pakistan, researchers reported a 55.2% prevalence of premature graying before age 30, commonly linked with factors like family history, nutritional deficiencies, hair loss, oily scalp, anxiety, and smoking.
March 2026 in “Journal of the American Academy of Dermatology” Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.
February 2026 in “Indian Journal of Community Health” Among female doctors in Dakshina Kannada, India, this study found a 21.25% prevalence of PCOS, significantly associated with marital status but not working hours, indicating a need to prioritize PCOS awareness and management among healthcare professionals.
January 2026 in “Medicina” This study conducted among medical students in Saudi Arabia found a 37.2% prevalence of premature hair graying and associated it with smoking, a keto diet, hair coloring, and family history, while suggesting that lifestyle changes may reduce its impact.
January 2026 in “Skin Appendage Disorders” This study found that hair shedding occurs in seven out of ten users of GLP-1 receptor agonists in real-world settings, a much higher prevalence than in clinical trials, which affects treatment adherence, especially among women experiencing significant weight loss.